{
    "2018-06-14": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Mylan (MYL) to Get CRL Again for Generic Advair from FDA",
                "features": {
                    "keywords": [
                        "Mylan",
                        "CRL",
                        "Generic Advair",
                        "FDA"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Allergan (AGN) Presents Positive Data on Glaucoma Candidate",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Positive Data",
                        "Glaucoma",
                        "Candidate"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Swiss Stock Market Finished Higher Following Afternoon Rally",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Finished Higher",
                        "Afternoon Rally"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Is the future of therapy online? Swiss drug giant Novartis thinks so",
                "features": {
                    "keywords": [
                        "future of therapy",
                        "online",
                        "Novartis"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}